Precision oncology startup Abdera launches with seed round
Vancouver-based precision oncology company Abdera Therapeutics has launched with a seed-stage financing of C$8 million.
26 January 2021•3 mins read
Vancouver-based precision oncology company Abdera Therapeutics has launched with a seed-stage financing of C$8 million.